| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |